Caffeine / рак

Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Over half of all new cancers are skin cancers and its incidence is on the rise due to increased recreational exposure to sunlight and depletion of the ozone layer (American Cancer Society's 2004 Facts & Figures; Nataraj, et al. (1995) Photochem. Photobiol. 62:218-230;

Method to identify tumor suppressor genes

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Throughout this application, various references are referred to by number within parentheses. Disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains. Full

Composition for treating hormonally-dependent cancers

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary

Substituted dicinnamoylquinides and their use in augmentation of adenonsine function

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

FIELD OF THE INVENTION The present invention relates generally to the field of use of alkyl, alkoxyl, halogenyl, or hydroxyl substituted dicinnamoylquinides. Specifically, the present invention relates to the use of the above-mentioned compounds to treat diseases or conditions that improve from

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid analogs as CCK antagonists

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting as agonists at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh, and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes, and Pittaway, Neuropharmacology 26:289-300, 1987), and as

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amico acid derivatives cyclized at the C-terminal

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE lNVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid derivatives cyclized at the C-terminal

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid derivatives cyclized at the C-terminal

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Pro-drugs for CCK antagonists

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

caffeine/рак

Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer

Method to identify tumor suppressor genes

Composition for treating hormonally-dependent cancers

Substituted dicinnamoylquinides and their use in augmentation of adenonsine function

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

Amino acid analogs as CCK antagonists

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

Amico acid derivatives cyclized at the C-terminal

Amino acid derivatives cyclized at the C-terminal

Amino acid derivatives cyclized at the C-terminal

Pro-drugs for CCK antagonists

Најкомплетнија база лековитог биља подржана науком